Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Premier Anti-Aging CoTSE:4934 +0.34%67 EV-to-EBIT is 7.65 as of Sep. 02, 2026, which is 4% below its 10-year median of 8.01. GuruFocus rates TSE:4934 with a GF Score™ of 67/100 and a GF Value™ of 円578.79 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,563 Consumer Packaged Goods companies, Premier Anti-Aging Co ranks better than 74.6% on this metric.
Premier Anti-Aging Co (TSE:4934) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Premier Anti-Aging Co's Enterprise Value for the quarter that ended in Jan. 2026 was 円2,384 Mil.
Premier Anti-Aging Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円210 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Premier Anti-Aging Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Premier Anti-Aging Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Premier Anti-Aging Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Premier Anti-Aging Co's EV-to-EBIT falls into.
Premier Anti-Aging Co's current Enterprise Value is 円1,606 Mil.
Premier Anti-Aging Co's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円210 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Premier Anti-Aging Co (TSE:4934) has a EV-to-EBIT of 7.65 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Premier Anti-Aging Co and its competitors. This is near median its historical median of 8.01. According to the industry distribution chart, Premier Anti-Aging Co ranks #397 out of 1563 companies in the Consumer Packaged Goods industry, placing it in the top 25.4%.
Is Premier Anti-Aging Co's EV-to-EBIT too high?
Premier Anti-Aging Co's current EV-to-EBIT of 7.65 is near median its 10-year median of 8.01. The Consumer Packaged Goods industry median EV-to-EBIT is 12.46. Premier Anti-Aging Co's value of 7.65 is 38.6% below this industry median. Based on the distribution chart, Premier Anti-Aging Co ranks #397 out of 1563 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Premier Anti-Aging Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Premier Anti-Aging Co's EV-to-EBIT compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Premier Anti-Aging Co ranks #397 out of 1563 companies for EV-to-EBIT. This puts Premier Anti-Aging Co in the upper half of its industry. The industry median EV-to-EBIT is 12.46. Premier Anti-Aging Co's value of 7.65 is 38.6% below this benchmark. While the company's 10-year median is 8.01 vs. the industry median of 12.46, Premier Anti-Aging Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.46, based on 1,563 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Premier Anti-Aging Co's current EV-to-EBIT of 7.65 is 38.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Premier Anti-Aging Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Premier Anti-Aging Co's current EV-to-EBIT is 7.65, which is near median its own 10-year median of 8.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Anti-Aging Co stock overvalued right now?
Based on GuruFocus' analysis, Premier Anti-Aging Co (TSE:4934) is currently considered Fairly Valued. The stock's GF Value™ is 円578.79, compared to a current price of 円597.00 — trading 3.1% above its estimated fair value. The current EV-to-EBIT is 7.65, which is near median its 10-year median of 8.01 and 38.6% below the Consumer Packaged Goods industry median of 12.46. Premier Anti-Aging Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Premier Anti-Aging Co (TSE:4934), the current EV-to-EBIT is 7.65 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Premier Anti-Aging Co (TSE:4934) Overvalued in 2026?
Based on GuruFocus' analysis, Premier Anti-Aging Co stock appears to be overvalued.
The current stock price of 円597.00 is trading 3.1% above its estimated GF Value™ of 円578.79.
GuruFocus considers Premier Anti-Aging Co to be Fairly Valued.
Key valuation signals for TSE:4934:
EV-to-EBIT: 7.65 (near median its 10-year median of 8.01)
GF Value™: 円578.79 vs. price of 円597.00 (3.1% above fair value)
Industry Position: 38.6% below the Consumer Packaged Goods median (#397 of 1563)
No single metric tells the full story. See the TSE:4934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Premier Anti-Aging Co Ltd operates in the anti-aging and recovery business fields. The anti-aging business mainly involves the manufacturing and sales of skincare, haircare, and inner care products, and it operates brands such as DUO, CANADEL, and CREAENCE. The recovery business mainly involves the manufacturing and sales of recovery wear, etc., through its subsidiary. The majority of revenue is derived from the Anti-aging Business.
67GF Score
Get the complete analysis for TSE:4934
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4934 has been successfully added to your 
